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We constructed dicistronic, subgenomic hepatitis C virus (HCV) replicons in which the sequence encoding the human
immunodeficiency virus (HIV) tat protein was placed in the upstream cistron, between the HCV 5NTR and a picornaviral 2A
proteinase sequence fused to the selectable marker Neo. Stably transformed Huh7 cells expressing secreted alkaline
phosphatase (SEAP) under transcriptional control of the HIV LTR promoter actively secreted SEAP following transfection with
these replicon RNAs. Extracellular SEAP activity correlated closely with intracellular HCV RNA levels, as determined by
Northern blotting and real-time RT-PCR analysis. These RNAs replicated efficiently despite the absence of core-protein-
coding sequence downstream of the HCV IRES. The replication efficiency of replicons derived from the HCV-N strain of HCV
was significantly greater than those derived from Con1 in transiently transfected cells. Using this reporter system, we have
demonstrated significant differences in the response to interferon -2b in cell lines containing replicons derived from these
two strains of HCV. © 2002 Elsevier Science (USA)alkaline phosphatase.
INTRODUCTION
Infection with hepatitis C virus (HCV) is an important
cause of chronic liver disease throughout the world. Up
to 70% of HCV infections become persistent, resulting in
chronic liver disease of varying degrees of severity (Alter,
1997). Although the incidence of HCV infection has been
reduced in developed countries in recent years by the
screening of blood units and other public health efforts,
in many areas infection remains uncontrolled. Over 170
million people are estimated to be infected with this virus
worldwide. Within the United States, approximately 1.5%
of the general population has serological evidence of
prior infection with HCV (Alter et al., 1999). Most of these
individuals remain actively infected with the virus and
are thus at risk for long-term complications, including
cirrhosis and hepatocellular carcinoma (Seeff, 1997). In-
terferon- is widely used in developed countries for the
treatment of such individuals. However, despite consid-
erable advances in the therapy of hepatitis C, even the
most effective treatment with interferon- in combination
with ribavirin fails to eliminate infection in more than 50%
of those infected with the most prevalent viral genotypes
(Lindsay et al., 2001; McHutchison et al., 1998). This high
frequency of treatment failure points to the need for more197specific, less toxic, and more active antiviral therapies
for HCV.
Despite the absence of fully permissive cell cultures
allowing efficient in vitro propagation of the virus, much
has been learned about HCV since its discovery a little
over a decade ago. Classified within the genus Hepaci-
virus of the family Flaviviridae, the viral genome is a
single-stranded, positive-sense RNA molecule approxi-
mately 9.6 kb in length (for a review, see Major and
Feinstone, 1997). The genomic RNA contains a single
large open reading frame (ORF) encoding a polyprotein
that is translated under the control of an internal ribo-
some entry site (IRES) located within the 342-nt-long 5
nontranslated RNA (5NTR) segment. This polyprotein
comprised several structural proteins (core, E1, E2, and
p7) and six nonstructural proteins (NS2, NS3, NS4A,
NS4B, NS5A, NS5B) and undergoes posttranslational
cleavage catalyzed by both cellular and viral-encoded
proteinases (Reed and Rice, 2000). The 5 and 3NTRs
are relatively well conserved among different HCV geno-
types and contain RNA signals involved in recognition of
the RNA by the viral replicase complex (Friebe et al.,
2001; Kim et al., 2002, Yanagi et al., 1999; Kolykhalov et
al., 2000).
Until recently, studies examining the involvement of
either viral RNA elements or proteins in the replication of
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subgenomic, dicistronic HCV RNAs in which most of
the structural protein-coding sequence was replaced
with sequence-encoding neomycin phosphotransferase
(Neo) (Lohmann et al., 1999). In an effort to retain optimal
translation directed by the upstream HCV IRES, the Neo
sequence was fused at its 5 end to the first 36 to 48 nt
of the HCV ORF in these RNAs. At its 3 end, the Neo
sequence was fused to the IRES of encephalomyocardi-
tis virus (EMCV), which directed the translation of down-
stream HCV sequence extending from either the NS2- or
the NS3-coding region to the 3 terminus of the genome
(Lohmann et al., 1999). G418 selection of human hepa-
toma cells that were transfected with these RNAs gave
rise to multiple antibiotic-resistant cell colonies contain-
ing high abundances of viral proteins and RNA (Lohmann
et al., 1999). Following the original description of these
replicons, cell-culture-adaptive mutations within the NS3,
NS5A, and NS5B proteins were shown to significantly
enhance the ability of the replicons described by Loh-
mann et al. to undergo autonomous amplification in cul-
tured Huh7 cells (Krieger et al., 2001; Blight et al., 2000).
In addition, replicons derived from a second genotype 1b
virus, HCV-N, were shown recently to be capable of
efficient replication in these cells in the absence of any
additional adaptive mutations (Guo et al., 2001; Ikeda et
al., 2002). These subgenomic replicons are likely to
prove valuable in high-throughput screening assays that
are aimed at identifying novel antiviral compounds with
activity against the HCV RNA replicase, and thus they
represent a substantial advance for this field.
In this article, we describe a useful refinement of these
subgenomic replicons that simplifies detection of HCV
RNA replication in both transiently transfected cells and
established cell clones selected under antibiotic pres-
sure. By modifying the upstream cistron so that it ex-
presses the tat protein of human immunodeficiency virus
(HIV) in addition to the Neo resistance marker, we de-
veloped replicon RNAs that are capable of signaling their
presence and abundance in cells by the secretion of
placental alkaline phosphatase (SEAP), expressed under
transcriptional control of the HIV LTR. This system is
unique in that it permits the autonomous replication of
the viral RNA to be monitored in intact cells by an
enzymatic assay of SEAP activity in the media bathing
the cells. Using these novel reporter replicons, we show
the effect of interferon- on the replication of RNAs
derived from two different strains of HCV in stably trans-
formed cell cultures.
RESULTS
Tat-SEAP enzyme reporter system
The HIV tat protein is a potent transcriptional transac-
tivator of its LTR promoter element. Unlike most known
eukaryotic transcriptional transactivators, tat functions
via an interaction with an RNA structure, the transactiva-
tion responsive element (TAR), rather than through inter-
action with DNA (Naryshkin et al., 1998; Cullen, 1998). In
the absence of tat, almost all RNA transcripts initiated by
the LTR promoter are terminated prematurely within
60–70 nucleotides of the start site. Tat acts to promote
the efficient elongation of premature transcripts, thereby
transactivating the transcription of functional mRNAs
from sequences placed under control of the HIV LTR
promoter. We have taken advantage of the small size of
the tat protein, and the manner in which it functionally
regulates the LTR promoter, to develop a system in which
a replication-competent, subgenomic HCV RNA express-
ing tat induces the expression of SEAP placed under
transcriptional control of the LTR in stably transformed
liver cells.
pEt2AN is an expression plasmid in which the HIV
tat-coding sequence is fused to sequence encoding the
FMDV 2A proteinase and the positive, selectable marker
neomycin phosphotransferase (Neo) (Fig. 1A). The small
FMDV 2A polypeptide sequence possesses autocatalytic
activity (Ryan and Drew, 1994), resulting in the scission of
the peptide backbone at its C-terminus and the release
of Neo. The translation of this mini-polyprotein is driven
by the EMCV IRES sequence located just upstream of
the protein-coding sequence (Fig. 1A), while transcrip-
tion is directed by a composite CMV/T7 promoter. We
used this plasmid to determine the level of SEAP ex-
pressed by stably transformed Huh7 cells (selected for
blasticidin resistance) in which the SEAP sequence had
been integrated under transcriptional control of the HIV
LTR. SEAP activity was measured in the supernatant
culture medium before and after transfection of the cells
with pEt2AN. Results obtained with one clonally isolated
cell line, En5-3, are shown in Fig. 1B.
This cell line produced a minimal basal level of SEAP
activity, while transfection of the cells with pEt2AN DNA
led to an approximately 100-fold increase in the secre-
tion of SEAP into the medium in response to tat expres-
sion (Fig. 1B). The secretion of SEAP from En5-3 cells
began to increase between 24 and 48 h after DNA
transfection and reached maximal levels at 72 to 96 h. In
contrast, the transfection of En5-3 cells with RNA tran-
scribed in vitro from pEt2AN led to an immediate in-
crease in SEAP activity that was maximal when first
assayed at 24 h posttransfection and subsequently de-
creased over time, reaching background levels 72 h later
(Fig. 1C). Since the cell culture medium bathing these
transfected cells was replaced at 24 h intervals in these
experiments (see Materials and Methods), the SEAP
activity measured at each time point reflected the
amount of the reporter protein secreted into the medium
over the preceding 24-h period. The delay in SEAP se-
cretion following DNA vs RNA transfection is likely to
represent the time required for RNA transcription to oc-
cur, while the rapid decline of SEAP following RNA trans-
fection reflects degradation of the transfected RNA and
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the tat protein translated from it. These encouraging
results suggested that the expression of tat from a rep-
licating subgenomic HCV RNA could provide a simple
and useful approach to monitoring the presence and
abundance of replicon RNA in En5-3 cells.
Subgenomic HCV replicons expressing tat
To test this hypothesis, we constructed a plasmid with
a transcriptional unit containing a dicistronic, sub-
genomic HCV replicon similar to that reported originally
by Lohmann et al. (1999), but in which the 5 cistron
encodes the tat-2A-Neo mini-polyprotein present in
pEt2AN (Fig. 1), fused in-frame downstream of the N-
terminal 14 amino acid residues of the HCV core protein
sequence (Fig. 2, BCtat2ANeo). The second cistron in
this replicon contained the NS3-5B segment of the Con1
HCV sequence placed under the translational control of
the ECMV IRES, as in the original HCV replicons (Loh-
mann et al., 1999). Because the effect of the fusion of the
N-terminal segment of the core protein on tat function
was uncertain, we also constructed a variant in which
the 5 cistron contained no HCV protein-coding se-
quence, and in which HCV IRES-directed translation ini-
tiated at the tat-coding sequence (Fig. 2, Btat2ANeo). To
enhance the potential replication of these replicons in
Huh7 cells, additional variants were engineered to con-
tain the S2205I (SI) cell-culture-adaptive mutation de-
scribed by Blight et al. (2000), and the R2889G (RG)
mutation described by Krieger et al. (2001), respectively
(these mutations are numbered according to the location
of the cognate residue within the HCV-N sequence)
(Ikeda et al., 2002) (Fig. 2).
Since the fusion of heterologous sequence directly
downstream of the HCV IRES may reduce the ability of
the HCV IRES to direct the internal initiation of translation
on a hybrid RNA (Reynolds et al., 1995; Rijnbrand et al.,
2001), we evaluated the translational activity of these
replicons by programming rabbit reticulocyte lysates for
translation with RNAs transcribed from these plasmids.
The results of these experiments confirmed the activity of
the FMDV 2A proteinase within the mini-polyprotein, as
protein species migrating with the mobilities expected
for the unprocessed Ctat2ANeo and the tat2ANeo pre-
cursor proteins and the fully processed Neo protein were
evident in SDS–PAGE gels of the translation products
from BCtat2ANeo and Btat2ANeo, respectively (Fig. 3A,
Lanes 2 and 3). The tat2A cleavage product was not
observed due to its small size. The results also sug-
gested that the absence of the core-protein-coding se-
quence in Btat2ANeo did in fact result in a significant
reduction in translation of the upstream cistron, as re-
flected in reduced quantities of Neo and the tat2ANeo
precursor protein in lysate programmed with Btat2ANeo
RNA (Fig. 3A, compare Lane 3 with Lane 2). In contrast,
the quantity of NS3 produced from the downstream cis-
tron was relatively increased in lysates programmed with
FIG. 1. Enzyme reporter system. (A) Organization of pEt2AN. Solid square,the CMV promoter region; solid arrow, T7 promoter; a thick line, EMCV
IRES; open box, open reading frame encoding polyprotein tat-2A-Neo. (B) SEAP expression following pEt2AN DNA transfection into En5-3 cells ().
The expression of tat from this plasmid is dependent on the CMV promoter. Note that SEAP activity is reported in arbitrary units. DNA was transfected
using Fugene reagent. SEAP expression from En5-3 cells without DNA transfection was also shown (f). (C) SEAP expression following electropo-
ration of En5-3 cells with RNA transcribed in vitro from pEt2AN (). SEAP expression from En5-3 cells without RNA transfection was also shown (f).
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Btat2ANeo RNA compared to BCtat2ANeo, suggesting
that the reduction in the activity of the HCV IRES in the
former RNA may have a complementary, beneficial effect
on the downstream EMCV IRES. This suggests that there
may be intercistronic competition for translation factors
between the HCV and EMCV IRES elements in these
replicon RNAs, as noted previously with other dicistronic
RNAs (Whetter et al., 1994b).
We next assessed the activities of tat proteins ex-
pressed from the upstream cistron in the BCtat2ANeo
and Btat2ANeo replicons (Fig. 2) in transient transfec-
tions of these replicon RNAs in En5-3 cells. SEAP activity
was monitored in the supernatant media at 72 h post-
transfection, in the absence of Neo selection. The results
of these experiments indicated that the tat protein was
significantly less active when expressed as a fusion
protein with the N-terminal 14 amino acid segment of
core (Fig. 3B, compare BCtat2ANeo, BCtat2ANeo(SI),
and BCtat2ANeo(RG) with Btat2ANeo, Btat2ANeo(SI),
and Btat2ANeo(RG) RNAs). Although the tat proteins ex-
pressed from these RNAs also have a C-terminal fusion
with the FMDV 2A proteinase, this C-terminal fusion
does not abrogate the transactivating activity of tat, as
evidenced in the experiments shown in Figs. 1B and 1C.
Replication of the RNAs did not contribute to the expression
of SEAP in the transient transfection experiment shown in
Fig. 3B, as the amount of SEAP induced by transfection of
an NS5B deletion mutant, Btat2ANeo(GDD), was only
slightly less than that induced by its parent, Btat2ANeo.
Similarly, the cell-culture-adaptive NS5A S2205I and
NS5B R2889G mutations (Fig. 2) engineered into these
RNAs had no effect on the level of SEAP expression
under these conditions (Fig. 3B).
Stable cell lines expressing SEAP under control of
replicon-mediated tat expression
Efforts to select stable, G418-resistant colonies follow-
ing transfection of En5-3 cells with Btat2ANeo or
BCtat2ANeo were unsuccessful. These results are con-
sistent with the very low frequency of colony formation
with the unmodified Con1 NS3-5B sequence, as reported
by Lohmann and others (Lohmann et al., 1999; Blight et
al., 2000; Ikeda et al., 2002). However, it was possible to
select G418-resistant En5-3 clones following transfection
of the modified Btat2ANeo containing the adaptive
S2205I mutation and BCtat2ANeo RNAs containing the
adaptive S2205I and R2889G mutations in NS5A and
NS5B (Fig. 2), respectively. The efficiency of colony for-
mation was substantially lower with these replicons,
even with the adaptive mutations, than what has been
reported in the literature (Lohmann et al., 2001; Blight et
al., 2000) or what we have observed previously (Ikeda et
al., 2002) with dicistronic, subgenomic HCV replicons.
This may reflect the use of the clonal, blasticidin-resis-
tant En5-3 cell line rather than the parental Huh7 cells.
FIG. 2. (A) Organization of subgenomic HCV RNA replicons encoding tat. Open reading frames are depicted as boxes, and nontranslated segments
of the dicistronic RNAs are depicted as solid lines. C indicates the N-terminal 14 amino acid core protein segment. (B) Additional mutations
engineered into the replicons, as described in the text.
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Moreover, the number of colonies selected with
Btat2ANeo(SI) RNA was approximately 10-fold lower than
with BCtat2ANeo(SI), suggesting that the absence of
the short, C core protein-coding sequence in
Btat2ANeo(SI) decreases the efficiency of colony selec-
tion. This could be due to the lower level of Neo ex-
pressed from this RNA (Fig. 3), or potentially to other
effects on replication of the subgenomic RNA.
Because replicons containing the genotype 1b, HCV-N
sequence have proven to be substantially superior to
Con1 replicons in their ability to induce the selection of
G418-resistant Huh7 cell clones (Ikeda et al., 2002; Guo
et al., 2001), we constructed a parallel series of replicons
containing the tat2ANeo sequence in the upstream cis-
tron with the downstream cistron, NS3-NS5B sequence
derived from HCV-N: Ntat2ANeo, Ntat2ANeo(SI), and
Ntat2ANeo(RG) (Fig. 2). Transfection with each of these
RNAs led to the selection of stable, G418-resistant colo-
nies. The number of G418-resistant colonies selected
with Ntat2ANeo(RG) was at least 100-fold higher than
with Btat2ANeo(SI). Overall, the efficiency of colony
selection observed with replicon RNAs that lacked
any core-protein-coding sequence (Fig. 2) could be
ordered as follows, from high to low: Ntat2ANeo(SI),
Ntat2ANeo(RG), Ntat2ANeo, Btat2ANeo(SI). This is con-
sistent with our previous observations with subgenomic
HCV replicons expressing only Neo from the upstream
cistron (Ikeda et al., 2002).
Replicon RNA was readily detected by Northern
analysis of G418-resistant cell lines selected following
transfection with BCtat2ANeo(SI), Btat2ANeo(SI), and
Ntat2ANeo(RG) (Fig. 4A). The abundance of the viral RNA
was significantly greater in the BCtat2ANeo(SI) cell line
selected for testing than in cell lines supporting replica-
tion of Btat2ANeo(SI) and Ntat2ANeo(RG). While the total
abundance of the replicon RNAs (see Materials and
Methods) increased in each of the cell lines studied over
a 120-h period following passage of the cells (Fig. 4A),
quantitative real-time RT-PCR assays showed a trend
toward a reduction in the intracellular abundance of the
replicon RNA relative to the abundance of GAPDH mRNA
as the cells approached confluence at 120 h (Fig. 4B).
This is similar to the reduction in intracellular abundance
of replicon RNAs reported recently by Pietschmann et al.
(2001). Once confluent, the intracellular abundance of the
replicon RNAs appeared to be similar in all three cell
lines studied. These results confirm that there is no
requirement for core-protein-coding sequence for repli-
cation of these dicistronic, subgenomic viral RNAs.
We also examined the cell lines shown in Fig. 4 for
viral protein expression as well as secretion of SEAP.
NS5A antigen was readily detected within the cytoplasm
in each cell line (Figs. 5A, 5C, and 5D), while no NS5A
antigen was detectable in normal En5-3 cells stained in
parallel (Fig. 5B). The abundance of the viral protein was
significantly greater in cells containing BCtat2ANeo(SI)
(Fig. 5A) than Btat2ANeo(SI) (Fig. 5C) or Ntat2ANeo(RG)
(Fig. 5D), consistent with the greater abundance of rep-
licon RNA detected in the former by Northern analysis
(Fig. 4A). In contrast, the SEAP activities expressed by
FIG. 3. (A) Product of in vitro translation reactions programmed with the indicated RNAs. (*) The expected positions of the major protein products
anticipated to be produced from the dicistronic RNAs. (B) SEAP activity present in tissue-culture media 72 h following transient transfection with
synthetic RNAs transcribed from the indicated plasmids.
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these cell lines showed a very different relationship to
the abundance of the replicon RNA. Each of the cell lines
secreted increased amounts of SEAP that were detect-
able above the low background activity present in En5-3
media (Fig. 6A). However, the level of SEAP activity ex-
pressed by the BCtat2A(SI) cell line was minimally
above background and much lower than that secreted by
the Btat2ANeo(SI) or Ntat2ANeo(RG) cell lines, despite a
higher abundance of viral RNA and viral proteins in the
former. Sequencing of cDNA amplified by RT-PCR from
the replicon RNAs present in the BCtat2A(SI) cells did
not identify any mutations within the upstream,
Ctat2ANeo cistron (data not shown), ruling out ad-
ventitious mutations as a potential cause for the mini-
mal level of SEAP expressed by these cells. The
Btat2ANeo(SI) and Ntat2ANeo(RG) cell lines demon-
strated robust secretion of the reporter protein, reaching
levels at least 100-fold above background after 5 days in
culture (Fig. 6A). These results are consistent with the
results of the transient transfections presented above
(Fig. 3B) and serve to confirm that the fusion of tat to the
N-terminal segment of the core protein sharply dimin-
ishes its ability to functionally transactivate the HIV LTR.
In the experiment shown in Fig. 6A, it is important to
note that the media was completely replaced at 24 h
intervals and that the cells were thoroughly washed
before being refed with fresh media. Thus, the results
shown represent the quantity of SEAP secreted by the
Btat2ANeo(SI) and Ntat2ANeo(RG) cells during succes-
sive 24 h periods. The secretion of SEAP correlated
closely with the abundance of replicon RNA in the
Btat2ANeo(SI) and Ntat2ANeo(RG) cells as determined
by densitometry of Northern blots (Fig. 6B, R2  0.983
and 0.939 by linear regression analysis, respectively). In
aggregate, these results demonstrate that the expres-
sion of tat from subgenomic HCV RNAs that are replicat-
ing in En5-3 cells effectively signals the secretion of
SEAP, thereby providing an easily measurable and accu-
rate marker of viral RNA replication that does not require
lysis or destruction of the cell monolayer.
Impact of cell-culture-adaptive mutations on the
replication of tat-expressing HCV replicons in
transient transfection assays
Further studies of these replicons focused on those
with no core protein sequence fused to tat, since the
fusion with the core sequence effectively inactivated the
transactivating function of tat. To determine whether the
activation of SEAP expression in En5-3 cells by tat was
sufficiently sensitive for detection of the replication of
subgenomic RNAs in transient transfection assays, rep-
licon RNAs were transfected into En5-3 cells using elec-
FIG. 4. (A) Northern blot analysis of replicon RNAs following passage of stable G418-resistant cell clones. (B) HCV RNA abundance detected by
TaqMan RT-PCR, normalized to a total cellular RNA standard and presented as copies of HCV RNA per picogram total cellular RNA. Note that the
same RNA samples were used as in Northern blot analysis in Fig. 4A. Open bar, BCtat2ANeo(SI); solid bar, Btat2ANeo(SI); gray bar, Ntat2ANeo(RG).
FIG. 5. Immunofluorescence detection of NS5A, 24 h after passage
of stable cell lines. (A) BCtat2ANeo(SI). (B) En5-3. (C) Btat2ANeo(SI).
(D) Ntat2ANeo(RG). Note the nuclear staining with DAPI.
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troporation, and the cells were followed for a period of 20
days in the absence of G418 selection. Included in this
experiment were the Btat2ANeo and Ntat2ANeo repli-
cons and mutants containing cell-culture-adaptive muta-
tions that were derived from them, as shown schemati-
cally in Fig. 2B. The supernatant media bathing the trans-
fected cells was removed and replaced with fresh media
at 24-h intervals, as in the experiment shown in Fig. 6A,
and the cells were collected by trypsinization and pas-
saged into fresh culture vessels at 7 and 14 days. The
levels of SEAP activity present in the media that was
removed from cells transfected with the replicon RNAs
based on the Btat2ANeo (Con1) sequence (Fig. 2) are
shown in Fig. 7A, while Fig. 7B shows SEAP activities in
media collected from cells transfected with replicons
derived from the HCV-N sequence.
The transfection of any of these replicon RNAs into
En5-3 cells resulted in a high initial level of SEAP ex-
pression that was present in the culture media as early
as 12 h after electroporation (Figs. 7A and 7B). This early,
high level of SEAP secretion persisted for approximately
3 days and was due to translation of the transfected input
RNA, as in the experiment shown in Fig. 3B. This high
initial SEAP level was also observed with replication-
defective mutants containing a deletion in the NS5B
sequence involving the GDD polymerase motif (GDD
mutants) (Figs. 7A and 7B). The SEAP activity secreted
into the media of cells transfected with Btat2ANeo(GDD)
and Ntat2ANeo(GDD) began to decrease by Day 4 and
reached baseline values similar to those observed with
normal En5-3 cells by 8 days after electroporation (Figs.
7A and 7B). In contrast, other, replication-competent
RNAs, particularly those derived from the HCV-N se-
quence, demonstrated increased levels of SEAP expres-
sion at later time points that were significantly above the
En5-3 cell background and thus indicative of replication
of the transfected RNA.
In experiments with replicon RNAs derived from the
Con1 sequence, significant increases in SEAP activity
above that observed with the Btat2ANeo(GDD) mutant
were seen only in cells transfected with Btat2ANeo(SI).
There was no apparent difference in the levels of
SEAP expressed by cells transfected with the Btat2ANeo
and Btat2ANeo(RG) replicons. Cells transfected with
Btat2ANeo(SI) demonstrated a low level but sustained
increase in SEAP activity above background beginning
about 10 days after transfection (Fig. 7A). However, the
secretion of SEAP was modest in magnitude, and never
more than several-fold above background. In sharp con-
trast, the HCV-N based replicons were remarkably more
potent in terms of their abilities to elicit sustained in-
creases in SEAP expression (Fig. 7B). Levels of SEAP
secretion up to 100-fold above background were ob-
served with Ntat2ANeo(SI) and Ntat2ANeo(RG), as well
as Ntat2ANeo(SIi5A). This latter replicon contains both
the S2205I substitution in NS5A and the deletion of a
natural four amino acid insertion that is present in the
NS5A sequence of HCV-N (Fig. 2B). This natural insertion
in NS5A, which was present in cDNA cloned from human
serum (Beard et al., 1999), has been shown to contribute
FIG. 6. (A) SEAP activity present in supernatant culture media at various time points following passage of stable cell lines. Btat2ANeo(SI) (Œ),
Ntat2ANeo(RG) (f), BCtat2ANeo(SI) (F), En5-3 (). Bars show the range of SEAP activity from duplicate experiments. (B) Linear regression analysis
of SEAP activity vs abundance of replicon RNA in the culture, as determined by densitometry of Northern blots. Btat2ANeo(SI) (Œ - - -), Ntat2ANeo(RG)
(f—).
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substantially to the replication capacity of replicons con-
taining the wild-type HCV-N sequence in Huh7 cells
(Ikeda et al., 2002). The results shown in Fig. 7 are
consistent with those we have published recently (Ikeda
et al., 2002) concerning the relative abilities of sub-
genomic RNAs containing the Con1 and HCV-N NS3-
NS5B sequences (with or without cell-culture-adaptive
mutations in NS5A and NS5B) to transduce the selection
of G418-resistant cell clones. These results also provide
independent confirmation of the ability of the S2205I and
R2889G mutations to enhance the replication capacity of
subgenomic, genotype 1b RNAs in cultured cells (Blight
et al., 2000; Krieger et al., 2001; Ikeda et al., 2002).
We also examined transiently transfected cells for ex-
pression of NS5A antigen at 12 and 19 days after elec-
troporation. These studies demonstrated that the propor-
tion of cells containing a detectable abundance of NS5A
was significantly greater following transfection with
Ntat2ANeo(RG) and Ntat2ANeo(SI) than Ntat2ANeo or
Btat2ANeo(SI) (Fig. 8, compare E, F, G, and H, with A, B,
C, and D, respectively). Thus, these results parallel
closely the results of the SEAP assays shown in Fig. 7.
Interestingly, the intensity of staining of individual posi-
tive cells appeared similar with each of the replicon
RNAs, suggesting that the level of SEAP expression may
correlate with the proportion of cells in which replicon
amplification is occurring, rather than the intracellular
abundance of the replicon under these conditions. As
this experiment was carried out in the absence of G418
selection, it is uncertain whether those cells that did not
stain positively for NS5A antigen contained levels of the
viral protein that were below the threshold of detection
or, alternatively, none at all.
Interferon suppression of HCV RNA replication
To demonstrate the utility of the tat-expressing HCV
replicons, we assessed the ability of recombinant inter-
feron -2b to suppress the replication of Btat2ANeo(SI)
and Ntat2ANeo(RG) in stable, G418-resistant cell clones.
Recently seeded cell cultures were fed with media con-
taining various concentrations of recombinant interferon
-2b ranging from 0 to 100 units/ml. The medium was
subsequently removed completely at 24 h intervals, and
the cells were washed thoroughly and refed with fresh
interferon-containing media. Results are shown in Fig. 9
and demonstrate dose-dependent inhibition of SEAP se-
cretion in both cell lines. As shown, cells cultured in the
absence of interferon, or at the lowest concentration of
interferon, showed an increasing level of SEAP secretion
over successive 24 h intervals, consistent with the
growth of the cells. At the highest concentration of inter-
feron tested (100 units/ml), this trend was reversed and
SEAP expression declined over time in the absence of
demonstrable cellular cytotoxicity. Independent quantita-
tive RT-PCR assays for HCV RNA demonstrated that the
decline in SEAP secretion was closely matched by sim-
ilar decreases in the intracellular abundance of RNA
(compare Fig. 9 and Fig. 10). The decline in intracellular
RNA preceded the decreases in SEAP secretion by ap-
proximately 24 h, most likely reflecting the kinetic delay
in tat signaling of SEAP secretion.
Surprisingly, the Ntat2ANeo(RG) replicon (Fig. 9B) was
approximately 10-fold more resistant to interferon than
the Btat2ANeo(SI) replicon (Fig. 9A). This relative inter-
feron resistance was reflected also in differences in the
degree of suppression of the intracellular abundance of
FIG. 7. SEAP activity following transient transfection of En5-3 cells with (A) Btat2Aneo and (B) Ntat2Aneo with various mutations. Wt(E), SI (f), RG
(Œ), dGDD (), N-5ASI (*). Arrow indicates trypsinization and passage of cells.
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HCV RNA following interferon treatment of these cells
(compare the decrease in Btat2ANeo(SI) RNA abun-
dance at different interferon concentrations in Fig. 10A
with the decreases in Ntat2ANeo(RG) RNA abundance
shown in Fig. 10B). A similar level of interferon resistance
was observed in separate experiments with an indepen-
dently selected, G418-resistant clone supporting the rep-
lication of the Ntat2ANeo(RG) replicon (data not shown),
suggesting that the resistance observed in Figs. 9B and
10B was not an idiosyncratic feature of the particular cell
clone tested. Studies are currently in progress to deter-
mine the molecular basis of this difference in the re-
sponse of the two replicons to interferon -2b.
DISCUSSION
We have described here a novel enzymatic reporter
system that permits the detection and quantitation of
HCV RNA replication in intact cell monolayers. The sys-
tem is based on the expression of the tat transactivator
protein by replicating subgenomic RNA replicons, and
the subsequent induction of SEAP synthesis in En5-3
cells that contain the SEAP gene under transcriptional
control of the HIV LTR promoter. SEAP is secreted effi-
ciently into the medium bathing these cells, where it is
readily quantified as an accurate marker of viral RNA
abundance. We adapted both Con-1 and HCV-N repli-
cons for use in this system and have shown that the
induction of SEAP is a useful measure of the replicon
RNA abundance in stable, G418-resistant cell lines (Fig.
6), as well as in cells that have been transiently trans-
fected by these RNAs (Fig. 7). Parallel measurements of
RNA abundance and SEAP expression in two separate
stable cell lines demonstrated a remarkable degree of
correlation (Fig. 6B), providing strong validation of the
system.
We have utilized this system to document the inhibition
of HCV-N and Con-1 HCV RNA replication in En5-3 cells
following treatment with recombinant interferon -2b
(Figs. 9 and 10). We found Ntat2ANeo(RG) to be about
10-fold less sensitive to interferon than Btat2ANeo(SI).
These results differ from those reported recently by Guo
et al. (2001), who found comparable interferon sensitivi-
ties with simple subgenomic dicistronic replicons con-
structed from these two viral sequences. We are cur-
rently investigating the molecular basis of the difference
we observed in the interferon responsiveness of these
replicons. Using the tat-expressing replicons, we have
also been able to demonstrate the inhibition of viral RNA
replication by prototype antiviral compounds that have
activity against the viral NS3 proteinase or NS5B RNA-
dependent, RNA polymerase (Minkyung, Yi, and Stanley
M. Lemon, unpublished data). Thus, we believe that this
unique and simple system for monitoring viral RNA rep-
lication is likely to prove useful in future antiviral drug
discovery efforts.
Because measurements of SEAP are technically sim-
pler and considerably less expensive than quantitative
RT-PCR assays for viral RNA, this system is likely to
prove advantageous for high throughput screening for
compounds with antiviral activity. An additional technical
advantage over HCV replicons that express luciferase or
most other conventional reporter proteins is that SEAP
activity is measured in supernatant culture fluids and
does not require the lysis of cells. This permits serial
measurements of the kinetics of RNA amplification in
single cultures of cells (Fig. 7). One potential drawback of
this system is that suppression of SEAP activity by can-
didate antiviral compounds could result from inhibition of
the activity of either the 2A protease or the tat, or even
(as with other published dicistronic HCV replicons) the
EMCV IRES. To address this issue, we established a
stably transformed cell line that constitutively expresses
the tat2ANeo polyprotein under the translational control
of the EMCV IRES (data not shown). This cell line (Et2AN)
was established by transfection of pEt2AN DNA (Fig. 1)
into En5-3 cells, followed by selection with G418. In
contrast to the results shown in Fig. 9, where interferon
-2b suppressed the secretion of SEAP from the repli-
con-bearing cell lines, there was no suppression of the
secretion of SEAP by the Et2AN cell line at comparable
concentrations of interferon (data not shown). This indi-
cates that the effect of interferon-2B on SEAP secretion
from the replicon cell line was due to specific suppres-
sion of the replication of HCV RNA, and not the fortuitous
suppression of 2A, tat, or EMCV IRES activity. It also
demonstrates the absence of nonspecific toxicity at the
concentrations of interferon tested and is consistent with
the suppression of HCV RNA abundance in these cells
shown in Fig. 10.
In developing these replicons, we have shown that
none of the viral core protein-coding sequence is re-
quired for replication of HCV RNA. There has been con-
siderable controversy over the role of this sequence in
viral translation since Reynolds et al. (1996) first sug-
gested that the 5 proximal 33 nt of the core sequence
were an integral part of the viral IRES and required for
efficient cap-independent translation. Recently, however,
Rijinbrand et al. (2001) demonstrated that the require-
ment is not for any specific sequence, but rather for a
lack of secondary RNA structure within the core-coding
sequence immediately downstream of the initiator AUG.
This is consistent with prior work by Honda et al. (1996)
that indicated that stable RNA structure within the vicinity
of the AUG is very detrimental to IRES-directed transla-
tion. Because of concerns that the 5 proximal core-
coding sequence might be required for optimal activity of
the HCV IRES, the original dicistronic, subgenomic HCV
replicons that were constructed by Lohmann et al. (1999)
contained RNA encoding 12 or 16 amino acids of the
core protein fused in-frame to the Neo gene in the up-
stream cistron. We found that replicons in which the tat
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sequence was fused directly to the HCV IRES had re-
duced translation of the upstream tat2ANeo mini-
polyprotein (Fig. 2A), but were nonetheless capable of
replication and the transduction of G418-resistant cell
lines (Figs. 4 and 5). These results demonstrate that
none of the core-coding sequence is required for viral
RNA replication. Other subgenomic HCV replicons have
recently been described in which all core protein se-
quence had been removed, but in these replicons trans-
lation of the upstream cistron was driven by a picorna-
viral IRES and the HCV 5NTR sequence functioned only
in template recognition by the RNA replicase complex
(Kim et al., 2002).
MATERIALS AND METHODS
Cells
En5-3 cells are a clonal cell line derived from Huh7
cells by stable transformation with the plasmid pLTR-
SEAP (see below). These cells were cultured in Dulbec-
co’s modified Eagle’s medium (Gibco-BRL) supple-
mented with 10% fetal calf serum, 2 g/ml blasticidin
(Invitrogen), penicillin, and streptomycin. Following trans-
fection with replicon RNAs, cells supporting replicon
amplification were selected and maintained in the above
media containing in addition 400 g/ml G418 (geneticin).
Cell lines were passaged once or twice per week.
Plasmids
The plasmid pLTR-SEAP was generated as follows.
pcDNA6/V5-His (Invitrogen) was digested with BglII-
BamHI to remove the CMV promoter. The vector was
then self-ligated, digested with EcoRV-NotI, and re-li-
gated to a DNA fragment encoding SEAP under tran-
scriptional control of the HIV LTR that was amplified from
pBCHIVSEAP (a generous gift of Dr. Bryan Cullen, Duke
University, Durham, NC) using the oligonucleotide primer
pairs; 5-CTAGCTAGCCTCGAGACCTGGAAAAACATGG-
AG-3 and 5-ATAAGAATGCGGCCGCTTAACCCGGGT-
GCGCGG-3. The resulting plasmid was transfected into
Huh7 cells using a nonliposomal transfection reagent
(FUGENE, Boehringer Mannheim), and stably resistant
cells were selected in the presence of blasticidin (Invitro-
gen). Blasticidin-resistant cell colonies were clonally se-
lected and subjected to further characterization. One,
designated En5-3, was selected for subsequent use due
to a low basal level of SEAP activity and efficient induc-
tion of SEAP following expression of the HIV tat protein.
To construct the plasmid pEt2AN, a DNA fragment
containing the EMCV IRES was amplified by PCR from
pEMCV-CAT (Whetter et al., 1994a) using paired primers
containing HindIII and StuI sites, respectively. DNA en-
coding the tat protein was similarly amplified from pCTAT
(also a generous gift of Dr. Cullen) with paired primers
containing StuI and EcoRI sites, respectively. Finally, a
DNA fragment encoding 15 amino acids of the foot-and-
mouth disease virus (FMDV) 2A protein was generated
by annealing the complementary primers 5-AATTCGAC-
CTTCTTAAGCTTGCGGGAGACGTCGAGTCCAACCCTG-
GGCCCG-3 and 5-GATCCGGGCCCAGGGTTGGACTC-
GACGTCTCCCGCAAGCTTAAGAAGGCG-3 to form a du-
plex DNA molecule with EcoRI and BamHI sticky ends,
respectively. The neo sequence was amplified from pRc-
CMV (Invitrogen) with primer pairs containing BglII and
NotI. These fragments were ligated to pcDNA6/V5-His
(Invitrogen) digested with HindIII and NotI to generate
pEt2AN.
To construct the replicon plasmid pBCtat2Aneo, the
genotype 1a infectious clone, pCV-H77c (generously pro-
vided by Dr. Robert Purcell, National Institutes of Health,
Bethesda, MD), was digested with SphI and the small
fragment was re-ligated. A single T-to-A nucleotide
change was engineered in this plasmid at nt 444 of the
HCV sequence using QuickChange (Statagene) mu-
tagenesis, generating a novel HpaI site at this position.
This resulting plasmid was digested with HpaI and XbaI
to generate a DNA fragment representing the HCV 1a
5NTR and immediately downstream sequence encoding
the first 14 amino acids of the HCV polyprotein. A second
DNA fragment representing the tat, 2A, and partial neo
sequence was excised from pEt2AN by digestion with
StuI and SphI. Finally, the plasmid pBNeo/wt (Fig. 1),
containing the sequence of the I377neo/NS3-3 replicon of
Lohmann et al. (generously provided by Dr. Michael
Murray of the Schering-Plough Research Institute), was
digested with SphI and XbaI to generate a fragment
representing the C-terminal neo sequence, EMCV IRES,
and downstream elements of the HCV replicon. These
three fragments were ligated to generate pBCtat2Aneo
(Fig. 1), which contains the 5NTR and downstream 42 nt
of core-coding sequence of the H77 strain of HCV
(genotype 1a) and the NS3-5B and 3NTR sequence of
the Con1 strain of HCV (genotype 1b). The plasmid
pBtat2Aneo was generated by QuickChange mutagene-
sis of pBCtat2Aneo, with deletion of the 42 nucleotides
of core-coding sequence and fusion of the tat sequence
directly downstream of 5NTR of HCV. pNtat2Aneo was
constructed by exchanging the large BsrGI-XbaI frag-
ment of pBtat2Aneo with the analogous HCV sequence
derived from the plasmid pHCV-N, resulting in replace-
ment of most of the NS3-NS5B and 3NTR sequence. A
similar strategy was employed for the construction of
variants of these replicon plasmids containing various
cell-culture-adaptive mutations or a deletion of the GDD
motif in the NS5B protein, as described by Ikeda et al.
(2002).
RNA transcription and transfection
RNA was synthesized with T7 MEGAScript reagents
(Ambion), after linearizing plasmids with XbaI. Following
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treatment with RNase-free Dnase to remove template
DNA and precipitation of the RNA with lithium chloride,
the RNA was transfected into En5-3 cells. Transfection
was done by electroporation, as described previously.
Briefly, 10 g RNA was mixed with 5  106 cells sus-
pended in 500 l phosphate-buffered saline, in a cuvette
with a gap width of 0.2 cm (Bio-Rad). Electroporation was
with two pulses of current delivered by the Gene Pulser
II electroporation device (Bio-Rad), set at 1.5 kV, 25 F,
and maximum resistance.
In vitro translation
In vitro transcribed RNA, prepared as described
above, was used to program in vitro translation reactions
in rabbit reticulocyte lysate (Promega). About 1 g of
each RNA, 2 l [35S]methionine (1000 Ci/mmol at 10
mCi/ml), and 1 l of an amino acid mixture lacking
methionine were included in each 50 l reaction mixture.
Translation was carried out at 30°C for 90 min. Transla-
tion products were separated by SDS–PAGE followed by
autoradiography or PhosphorImager (Molecular Dynam-
ics) analysis.
Northern analysis for HCV RNA
We seeded replicon-bearing cells into six-well plates
at a density of 2  105 cells/well and harvested the RNA
from individual wells at daily intervals. Total cellular
RNAs were extracted with TRizol reagent (Gibco-BRL)
and quantified by spectrophotometry at 260 nm. One-half
of the total RNA extracted from each well was loaded
onto a denaturing agarose-formaldehyde gel, subjected
to electrophoresis, and transferred to positively charged
Hybond-N nylon membranes (Amersham-Pharmacia
Biotec) using reagents provided with the NorthernMax
Kit (Ambion). RNAs were immobilized on the membranes
by UV-crosslinking. The membrane was hybridized with a
32P-labeled antisense riboprobe complementary to the
3-end of NS5B sequence (HCV nt 8990–9275), and the
hybridized probe was detected by exposure to X-ray film.
FIG. 8. Immunofluorescence analysis of NS5A antigen 12 days and 19 days following transfection of En5-3 cells with the replicon RNAs indicated.
Cells were cultured in the absence of G-418.
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Indirect immunofluorescence analysis
Cells were grown on chamber slides until 70–80%
confluent, washed three times with PBS, and fixed in
methanol/acetone (1:1 V/V) for 10 min at room tempera-
ture. A 1:10 dilution of a primary, murine monoclonal
antibody to NS5A (MAB7022P, ME Biotechnology Ser-
vices) was prepared in PBS containing 3% bovine serum
albumin and incubated with the fixed cells for 1 h at room
temperature. Following additional washes with PBS, spe-
cific antibody binding was detected with a goat anti-
mouse IgG FITC-conjugated secondary antibody (Sigma)
diluted 1:70. Cells were washed with PBS, counter-
stained with DAPI, and mounted in Vectashield mounting
medium (Vector Laboratories) prior to examination by a
Zeiss AxioPlan2 fluorescence microscope.
Alkaline phosphatase assay
SEAP activity was measured in 20-l aliquots of the
supernatant culture fluids using the Phospha-Light
Chemiluminescent Reporter Assay (Tropix), and the man-
FIG. 9. Suppression of HCV replicon amplification by interferon -2b. (A) SEAP activity secreted from cells supporting replication of Btat2ANeo(SI)
over successive 24-h intervals following addition of interferon to the medium. (B) SEAP secretion from Ntat2ANeo(RG) cells. Interferon concentrations
were as follows: (*) 100 units/ml; () 10 units/ml; (Œ) 1 unit/ml; (f) no interferon. SEAP expression from En5-3 cells without interferon treatment was
also shown (). SEAP expression from En5-3 cells was not affected by interferon treatment (data not shown).
FIG. 10. Suppression of HCV replicon RNA abundance by interferon -2b in the cell cultures depicted in Fig. 9. (A) Intracellular abundance of HCV
RNA in cells supporting replication of Btat2ANeo(SI) at 24, 72, and 120 h following addition of interferon to the medium. (B) RNA abundance in
Ntat2ANeo(RG) cells under similar conditions. HCV RNA was quantified by RT-PCR analysis and normalized to a total cellular RNA standard (see
legend to Fig. 4B). Interferon concentrations were as follows: (*) 100 units/ml; () 10 units/ml; (Œ) 1 unit/ml; (f) no interferon.
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ufacturer’s suggested protocol reduced one-third in
scale. The luminescent signal was read using a TD-
20/20 Luminometer (Turner Designs, Inc.). In most time-
course experiments, the culture medium was replaced
every 24 h. Thus, the SEAP activity measured in these
fluids reflected the daily production of SEAP by the cells.
Real-time quantitative RT-PCR analysis of HCV RNA
Quantitative RT-PCR assays were carried out using
TaqMan chemistry on a PRISM 7700 instrument (ABI).
For detection and quantitation of HCV RNA, we used
primers complementary to the 5NTR region of HCV
(Takeuchi et al., 1999), with in vitro transcribed HCV RNA
included in the assays as a standard. Results were
normalized to the estimated total RNA content of the
sample, as determined by the abundance of cellular
GAPDH mRNA detected in a similar real-time RT-PCR
assay using reagents provided with TaqMan GAPDH
Control Reagents (Human) (Applied Biosystems).
Sequence analysis of cDNA from replicating HCV
RNAs
HCV RNA was extracted from cells, converted to
cDNA, and amplified by PCR as described previously
(Ikeda et al., 2002). First-strand cDNA synthesis was
carried out with Superscript II reverse transcriptase
(Gibco-BRL), and PFU-Turbo DNA polymerase (Strat-
agene) was used for PCR amplification of the DNA. The
amplified DNAs were subjected to direct sequencing
using an ABI 9600 automatic DNA sequencer.
Interferon treatment of cell cultures
Selected replicon-bearing cell lines were seeded into
12-well plates. The media was replaced 24 h later with
fresh, G418-free media containing various concentra-
tions of recombinant interferon -2b ranging from 0 to
100 units/ml. The medium was subsequently completely
removed every 24 h; the cells washed and refed with
fresh interferon-containing media. SEAP activity was
measured in the media removed from the cells as de-
scribed above.
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